EP2964258
Mótefni sem binda IL-23
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
4.3.2014EP published:
2.9.2020EP application number:
14761062.0
EP translation filed:
24.9.2020Grant published:
15.10.2020EPO information:
European Patent Register
Max expiry date:
3.3.2034Expiry date:
3.3.2027Next due date:
31.3.2027
Title:
ANTIBODIES THAT BIND IL-23
Timeline
Today
4.3.2014EP application
2.9.2020EP Publication
24.9.2020Translation submitted
15.10.2020Registration published
3.3.2027Expires
Owner
Name:
Eli Lilly and CompanyAddress:
Lilly Corporate Center, Indianapolis, IN 46285, US
Inventor
Name:
BEIDLER, Catherine BrautigamAddress:
Indianapolis Indiana 46206-6288, US
Name:
BRIGHT, Stuart WillisAddress:
Indianapolis Indiana 46206-6288, US
Name:
GIRARD, Daniel ScottAddress:
Indianapolis Indiana 46206-6288, US
Name:
KIKLY, Kristine KayAddress:
Indianapolis Indiana 46206-6288, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201361774732 PDate:
8.3.2013Country:
US
Supplementary protection
SPC number:
SPC441
Classification
Categories:
A61K 39/395
Annual fees
Number
Paid
Expires
Payer
Number: 8
Paid: 17.2.2021
Expires: 3.3.2022
Payer: Patice ehf.
Number: 9
Paid: 17.2.2022
Expires: 3.3.2023
Payer: Patice ehf.
Number: 10
Paid: 22.2.2023
Expires: 3.3.2024
Payer: Árnason Faktor ehf.
Number: 11
Paid: 29.2.2024
Expires: 3.3.2025
Payer: Árnason Faktor ehf.
Number: 12
Paid: 21.2.2025
Expires: 3.3.2026
Payer: Árnason Faktor ehf.
Number: 13
Paid: 5.3.2026
Expires: 3.3.2027
Payer: Árnason Faktor ehf.